Telomir Pharmaceuticals, Inc. (TELO)
About Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$10.4M
- Total assets
- $7.3M
- Market cap
- $83.2M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $83.2M
- Shares outstanding
- 72.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 9, 2024
Telomir Pharmaceuticals, Inc. (TELO) Stock Price
- Reported a net loss of $10.4M.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Telomir Pharmaceuticals, Inc..
Write a review
News about Telomir Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Telomir Pharmaceuticals, Inc.: frequently asked questions
Is Telomir Pharmaceuticals, Inc. an American company?
Telomir Pharmaceuticals, Inc. is a US-based company headquartered in Miami, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Telomir Pharmaceuticals, Inc. headquartered?
Telomir Pharmaceuticals, Inc. is headquartered in Miami, Florida, United States.
Is Telomir Pharmaceuticals, Inc. publicly traded?
Yes — Telomir Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol TELO on the NASDAQ.
What does Telomir Pharmaceuticals, Inc. do?
Telomir Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
